Examining the Role of Physical Activity Interventions in Modulating Androgens and Cardiovascular Health in Postmenopausal Women: A Narrative Review.

Cara G Elliott, Sol Vidal-Almela, Paula Harvey, Emma O'Donnell, Jennifer L Scheid, Sarah Visintini, Jennifer L Reed
Author Information
  1. Cara G Elliott: Exercise Physiology and Cardiovascular Health Lab, Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  2. Sol Vidal-Almela: Exercise Physiology and Cardiovascular Health Lab, Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  3. Paula Harvey: Women's College Hospital, University of Toronto, Toronto, Ontario, Canada.
  4. Emma O'Donnell: School of Sport and Exercise Health Sciences, National Centre of Sports and Exercise Medicine, Loughborough University, Loughborough, England, United Kingdom.
  5. Jennifer L Scheid: Department of Health Promotion and Physical Therapy, Daemen College, Amherst, New York, USA.
  6. Sarah Visintini: Berkman Library, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
  7. Jennifer L Reed: Exercise Physiology and Cardiovascular Health Lab, Division of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Abstract

A growing body of literature has examined the role of physical activity (PA) in modifying the effects of estrogen withdrawal on cardiovascular health in postmenopausal women, but the impact of PA on androgens is less clear. Changes in androgen concentrations following regular PA may improve cardiovascular health. This narrative review summarizes the literature assessing the impact of PA interventions on androgens in postmenopausal women. The association between changes in androgen concentrations and cardiovascular health following PA programs is also examined. Randomized controlled trials were included if they (i) implemented a PA program of any type and duration in postmenopausal women and (ii) measured changes in androgen concentrations. Following PA interventions, no changes in androstenedione, conflicting changes in dehydroepiandrosterone/dehydroepiandrosterone-sulfate, and increases in sex hormone-binding globulin concentrations were found. Total testosterone decreased following aerobic PA but increased after resistance training. Most aerobic PA interventions led to reductions in free testosterone. A combination of caloric restriction and/or fat loss enhanced the influence of PA on most androgens. Evidence exploring the relationship between changes in androgens and cardiovascular health indicators was scarce and inconsistent. PA has shown promise in modifying the concentrations of some androgens (free and total testosterone, sex hormone-binding globulin), and remains a well-known beneficial adjuvant option for postmenopausal women to manage their cardiovascular health. Fat loss influences the effect of PA on androgens, but the synergistic role of PA and androgens on cardiovascular health merits further examination. Many research gaps remain regarding the relationship between PA, androgens, and cardiovascular disease in postmenopausal women.

References

  1. J Am Coll Cardiol. 2018 Oct 16;72(16):1986 [PMID: 30309479]
  2. J Clin Oncol. 2009 Sep 20;27(27):4492-9 [PMID: 19687339]
  3. Reprod Biol Endocrinol. 2009 May 12;7:44 [PMID: 19433001]
  4. Pharmacol Res. 2021 Sep;171:105758 [PMID: 34242799]
  5. Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):471-7 [PMID: 25550203]
  6. Int J Environ Res Public Health. 2021 Jan 14;18(2): [PMID: 33466649]
  7. Circ Res. 2016 Apr 15;118(8):1273-93 [PMID: 27081110]
  8. Br J Sports Med. 2020 Dec;54(24):1451-1462 [PMID: 33239350]
  9. Front Horm Res. 2019;53:135-161 [PMID: 31499509]
  10. Lancet Diabetes Endocrinol. 2015 Dec;3(12):980-92 [PMID: 26358173]
  11. Menopause. 2017 Aug;24(8):970-979 [PMID: 28609390]
  12. Menopause. 2019 Feb;26(2):220-224 [PMID: 30130283]
  13. Prz Menopauzalny. 2020 Dec;19(4):151-154 [PMID: 33488324]
  14. Maturitas. 2016 Nov;93:83-88 [PMID: 27137981]
  15. J Endocrinol. 2016 Jul;230(1):R13-25 [PMID: 27113851]
  16. J Clin Endocrinol Metab. 1995 Apr;80(4):1429-30 [PMID: 7714119]
  17. J Clin Hypertens (Greenwich). 2021 Jul;23(7):1413-1419 [PMID: 34105885]
  18. Eur Heart J. 2020 Apr 14;41(15):1490-1499 [PMID: 31698425]
  19. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4660-4666 [PMID: 31498871]
  20. J Strength Cond Res. 2019 May;33(5):1276-1285 [PMID: 28135215]
  21. Cardiovasc Res. 2021 Aug 29;117(10):2252-2262 [PMID: 32941598]
  22. Circulation. 2020 Dec 22;142(25):e506-e532 [PMID: 33251828]
  23. Coron Artery Dis. 2007 Feb;18(1):9-13 [PMID: 17172924]
  24. Sports Med. 2011 Jan 1;41(1):1-15 [PMID: 21142281]
  25. Endocr Rev. 2003 Apr;24(2):152-82 [PMID: 12700178]
  26. Nat Rev Dis Primers. 2015 Apr 23;1:15004 [PMID: 27188659]
  27. Menopause. 2020 Feb;27(2):199-207 [PMID: 31663986]
  28. BMJ. 2006 Jan 14;332(7533):73-8 [PMID: 16371403]
  29. J Am Coll Cardiol. 2018 Jun 5;71(22):2555-2566 [PMID: 29852978]
  30. Metab Syndr Relat Disord. 2012 Dec;10(6):452-7 [PMID: 22989086]
  31. J Clin Endocrinol Metab. 2010 Feb;95(2):740-7 [PMID: 19934360]
  32. JAMA. 2006 Mar 15;295(11):1288-99 [PMID: 16537739]
  33. Vital Health Stat 10. 2012 Jan;(252):1-207 [PMID: 22834228]
  34. Res Sports Med. 2010 Oct;18(4):236-50 [PMID: 21058209]
  35. Clin Endocrinol (Oxf). 2012 Oct;77(4):541-7 [PMID: 22106826]
  36. CJC Open. 2021 Sep 25;4(2):115-132 [PMID: 35198930]
  37. BMC Womens Health. 2015 Aug 22;15:64 [PMID: 26296869]
  38. Maturitas. 2008 Apr 20;59(4):394-404 [PMID: 18499368]
  39. Health Rep. 2019 Aug 21;30(8):3-10 [PMID: 31454407]
  40. J Clin Endocrinol Metab. 2014 Oct;99(10):3489-510 [PMID: 25279570]
  41. J Steroid Biochem Mol Biol. 2010 Oct;122(1-3):42-52 [PMID: 20036327]
  42. J Gerontol A Biol Sci Med Sci. 2003 Mar;58(3):266-70 [PMID: 12634293]
  43. Fundam Clin Pharmacol. 2010 Dec;24(6):675-85 [PMID: 20199585]
  44. J Clin Endocrinol Metab. 1997 Aug;82(8):2396-402 [PMID: 9253307]
  45. Climacteric. 2014 Dec;17(6):625-34 [PMID: 24559253]
  46. Cancer Epidemiol Biomarkers Prev. 2004 Jul;13(7):1099-105 [PMID: 15247119]
  47. Eur J Endocrinol. 2010 Oct;163(4):699-708 [PMID: 20685832]
  48. Med Sci Sports Exerc. 2001 Apr;33(4):635-43 [PMID: 11283441]
  49. Med Sci Sports Exerc. 1998 Jun;30(6):893-8 [PMID: 9624648]
  50. J Funct Morphol Kinesiol. 2020 May 31;5(2): [PMID: 33467251]
  51. J Clin Endocrinol Metab. 2005 Jul;90(7):3847-53 [PMID: 15827095]
  52. Nat Rev Cardiol. 2009 Aug;6(8):532-42 [PMID: 19564884]
  53. Sci Rep. 2020 Nov 16;10(1):19837 [PMID: 33199796]
  54. Metabolism. 2012 Feb;61(2):193-201 [PMID: 21820132]
  55. Maturitas. 2004 Aug 20;48(4):360-71 [PMID: 15283928]
  56. J Clin Oncol. 2010 Mar 20;28(9):1458-66 [PMID: 20159820]
  57. J Clin Oncol. 2012 Jul 1;30(19):2314-26 [PMID: 22614972]
  58. Menopause. 2019 Apr;26(4):417-422 [PMID: 30461557]
  59. Eur J Appl Physiol. 2020 Jun;120(6):1277-1287 [PMID: 32266494]
  60. Vasc Health Risk Manag. 2008;4(2):453-62 [PMID: 18561521]
  61. Int J Obes (Lond). 2021 Jun;45(6):1298-1309 [PMID: 33727632]
  62. J Obstet Gynaecol Can. 2021 Dec;43(12):1438-1443.e1 [PMID: 34895581]
  63. Hum Reprod. 2009 Sep;24(9):2276-85 [PMID: 19520711]
  64. Breast Cancer Res. 2015 Sep 02;17:120 [PMID: 26330303]
  65. Endocr Relat Cancer. 2015 Oct;22(5):863-76 [PMID: 26338699]
  66. Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1725-1734 [PMID: 31383718]

Word Cloud

Created with Highcharts 10.0.0PAandrogenscardiovascularhealthpostmenopausalwomenconcentrationschangesandrogenfollowinginterventionstestosteroneliteratureexaminedrolemodifyingimpactsexhormone-bindingglobulinaerobicfreelossrelationshipgrowingbodyphysicalactivityeffectsestrogenwithdrawallessclearChangesregularmayimprovenarrativereviewsummarizesassessingassociationprogramsalsoRandomizedcontrolledtrialsincludedimplementedprogramtypedurationiimeasured Followingandrostenedioneconflictingdehydroepiandrosterone/dehydroepiandrosterone-sulfateincreasesfoundTotaldecreasedincreasedresistancetrainingledreductionsA combinationcaloricrestrictionand/orfatenhancedinfluenceEvidenceexploringindicatorsscarceinconsistentshownpromisetotalremainswell-knownbeneficialadjuvantoptionmanageFatinfluenceseffectsynergisticmeritsexaminationManyresearchgapsremainregardingdiseaseExaminingRolePhysicalActivityInterventionsModulatingAndrogensCardiovascularHealthPostmenopausalWomen:NarrativeReview

Similar Articles

Cited By (2)